ELVElevance Health

$412.79+33% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.3 points).

1 to watch, 2 neutral
Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +9% a year.

Earnings trend−4% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−1.3 points operating

Trailing-twelve-month operating margin, 2.7% now against 4.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ELV growing?

Elevance Health has grown revenue 6.7% a year over three years and 9.3% a year over five, with earnings per share compounding at −5.0%.

+6.7%

Revenue growth, 3-year annual rate · Healthcare Plans median +7.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+9.3%

Revenue growth, 5-year rate · +6.7% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−5.0%

Earnings per share, 3-year rate · revenue +6.7% · earnings lagged revenue: the growth is costing something

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$138.6B
Revenue FY2022
$156.6B
Revenue FY2023
$171.3B
Revenue FY2024
$177.0B
Revenue FY2025
$199.1B

Annual income statements as filed with the SEC.